Literature DB >> 17503132

Stress and multiple sclerosis.

David C Mohr1.   

Abstract

Increasing numbers of studies are reporting an association between stressful life events and exacerbation in multiple sclerosis. We review findings that begin to suggest psychological, social and biological factors that may be involved in this relationship. Depression, negative attributions, poor coping, and low social support have been implicated as aggravating the relationship between stress and exacerbation. A model of glucocorticoid resistance on immune cells is also presented as one potential biological mechanism. It is emphasized that to date there is no evidence of causal relationships. It is argued that a purely causal relationship, in which stressful events alone trigger exacerbation, is unlikely. Rather, we propose that stress may be one factor among many that influence risk of exacerbation.

Entities:  

Mesh:

Year:  2007        PMID: 17503132     DOI: 10.1007/s00415-007-2015-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

Review 1.  A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis.

Authors:  David C Mohr; Daniel Pelletier
Journal:  Brain Behav Immun       Date:  2006-01       Impact factor: 7.217

2.  A serial study of new MS lesions and the white matter from which they arise.

Authors:  D E Goodkin; W D Rooney; R Sloan; P Bacchetti; L Gee; M Vermathen; E Waubant; M Abundo; S Majumdar; S Nelson; M W Weiner
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

Review 3.  The role of stress-response systems for the pathogenesis and progression of MS.

Authors:  Stefan M Gold; David C Mohr; Inge Huitinga; Peter Flachenecker; Esther M Sternberg; Christoph Heesen
Journal:  Trends Immunol       Date:  2005-10-07       Impact factor: 16.687

4.  Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

Authors:  F Then Bergh; T Kümpfel; C Trenkwalder; R Rupprecht; F Holsboer
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

5.  Emotional stress and coping in multiple sclerosis (MS) exacerbations.

Authors:  S Warren; K G Warren; R Cockerill
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

6.  Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system.

Authors:  C Morale; J Brouwer; N Testa; C Tirolo; N Barden; C D Dijkstra; S Amor; B Marchetti
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

7.  Psychological stress as risk factor for exacerbations in multiple sclerosis.

Authors:  P Nisipeanu; A D Korczyn
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

8.  Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis.

Authors:  David C Mohr; Claude Genain
Journal:  J Psychosom Res       Date:  2004-08       Impact factor: 3.006

9.  Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis.

Authors:  David C Mohr; Donald E Goodkin; Sarah Nelson; Darcy Cox; Michael Weiner
Journal:  Psychosom Med       Date:  2002 Sep-Oct       Impact factor: 4.312

10.  Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis.

Authors:  Lisa M L van Winsen; Daan F R Muris; Chris H Polman; Christine D Dijkstra; Timo K van den Berg; Bernard M J Uitdehaag
Journal:  J Clin Endocrinol Metab       Date:  2004-11-16       Impact factor: 5.958

View more
  10 in total

Review 1.  Stress in multiple sclerosis: review of new developments and future directions.

Authors:  Jesus Lovera; Tara Reza
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

2.  Stress and the risk of multiple sclerosis.

Authors:  T Riise; D C Mohr; K L Munger; J W Rich-Edwards; I Kawachi; A Ascherio
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

3.  Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: description and outcomes.

Authors:  Kimberly Beckwith McGuire; Jelena Stojanovic-Radic; Lauren Strober; Nancy D Chiaravalloti; John DeLuca
Journal:  Int J MS Care       Date:  2015 Jan-Feb

Review 4.  Life issues in multiple sclerosis.

Authors:  Rex D Simmons
Journal:  Nat Rev Neurol       Date:  2010-09-21       Impact factor: 42.937

5.  Contribution of symptom clusters to multiple sclerosis consequences.

Authors:  Shahnaz Shahrbanian; Pierre Duquette; Ayse Kuspinar; Nancy E Mayo
Journal:  Qual Life Res       Date:  2014-09-17       Impact factor: 4.147

6.  Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study.

Authors:  Adam B Levin; Emily J Hadgkiss; Tracey J Weiland; Claudia H Marck; Dania M van der Meer; Naresh G Pereira; George A Jelinek
Journal:  Behav Neurol       Date:  2014-11-12       Impact factor: 3.342

Review 7.  Th17-cells in depression: Implication in multiple sclerosis.

Authors:  Mikhail Melnikov; Anna Lopatina
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

Review 8.  Meditation as an adjunct to the management of multiple sclerosis.

Authors:  Adam B Levin; Emily J Hadgkiss; Tracey J Weiland; George A Jelinek
Journal:  Neurol Res Int       Date:  2014-07-01

9.  Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.

Authors:  Sara Carletto; Martina Borghi; Gabriella Bertino; Francesco Oliva; Marco Cavallo; Arne Hofmann; Alessandro Zennaro; Simona Malucchi; Luca Ostacoli
Journal:  Front Psychol       Date:  2016-04-21

10.  The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients.

Authors:  Aleksandra Kołtuniuk; Magdalena Kazimierska-Zając; Kinga Cisek; Justyna Chojdak-Łukasiewicz
Journal:  Psychol Res Behav Manag       Date:  2021-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.